---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-021628"
form_type: "8-K"
ticker: "ASBP"
cik: "0001847345"
company_name: "Aspire Biopharma Holdings, Inc."
filed_at: "2024-05-28T23:59:59+00:00"
generated_at: "2026-06-01T08:17:06.200659+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# PowerUp Acquisition Corp. shareholders approve extension of business combination deadline to Feb 2025

## Summary
- Shareholders approved extending the deadline to consummate an initial business combination from May 23, 2024 to February 17, 2025.
- Shareholders also approved removing the requirement that the company have at least $5,000,001 in net tangible assets before closing a deal.
- A total of 1,226,085 Class A ordinary shares were redeemed for cash in connection with the meeting.
- Both proposals passed with overwhelming support: Extension 7,753,807 for / 62,254 against; NTA removal 7,816,061 for / 0 against.

## SEC filing metadata
- accession: 0001493152-24-021628
- form_type: 8-K
- ticker: ASBP
- cik: 0001847345
- company_name: Aspire Biopharma Holdings, Inc.
- filed_at: 2024-05-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847345/000149315224021628/0001493152-24-021628-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847345/000149315224021628/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-021628
- JSON: https://secwatch.observer/filing/0001493152-24-021628.json
- Plain text: https://secwatch.observer/filing/0001493152-24-021628.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.